JORDAN; Craig T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for JORDAN; Craig T..The latest application filed is for "methods of detecting and treating venetoclax-resistant acute myeloid leukemia".

Company Profile

2.17.21

JORDAN; Craig T. - Aurora CO
Jordan; Craig T. - Rochester NY
Jordan; Craig T. - Little Rock AR US
Jordan; Craig T. - Webster NY US
JORDAN, CRAIG T. - LEXINGTON KY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Detecting And Treating Venetoclax-resistant Acute Myeloid Leukemia App 20220136068 - SMITH; Clayton ; et al.	2022-05-05
Stat3 Transcription Factor Inhibitors And Methods Of Using The Same App 20220017476 - REIGAN; Philip ; et al.	2022-01-20
Use Of Parthenolide Derivatives As Antileukemic And Cytotoxic Agents App 20190231790 - Crooks; Peter A. ; et al.	2019-08-01
Use of parthenolide derivatives as antileukemic and cytotoxic agents Grant 10,251,890 - Crooks , et al.	2019-04-09
Melampomagnolide B derivatives Grant 9,920,063 - Bommagani , et al. March 20, 2	2018-03-20
Melampomagnolide B derivatives Grant 9,908,892 - Janganati , et al. March 6, 2	2018-03-06
Use Of Parthenolide Derivatives As Antileukemic And Cytotoxic Agents App 20170224698 - Crooks; Peter A. ; et al.	2017-08-10
Melampomagnolide B Derivatives App 20160368929 - Janganati; Venumadhav ; et al.	2016-12-22
Melampomagnolide B Derivatives App 20160368928 - Bommagani; Shobanbabu ; et al.	2016-12-22
Melampomagnolide B derivatives Grant 9,487,536 - Bommagani , et al. November 8, 2	2016-11-08
Melampomagnolide B derivatives Grant 9,469,650 - Janganati , et al. October 18, 2	2016-10-18
Use of parthenolide derivatives as antileukemic and cytotoxic agents Grant 9,447,112 - Crooks , et al. September 20, 2	2016-09-20
Parthenolide Derivatives, Methods For Their Preparation And Their Use As Anticancer Agents App 20160115508 - Fasan; Rudi ; et al.	2016-04-28
Use Of Parthenolide Derivatives As Antileukemic And Cytotoxic Agents App 20150259356 - Crooks; Peter A. ; et al.	2015-09-17
Melampomagnolide B Derivatives App 20150203508 - Bommagani; Shobanbabu ; et al.	2015-07-23
Use of parthenolide derivatives as antileukemic and cytotoxic agents Grant 9,045,490 - Crooks , et al. June 2, 2	2015-06-02
Melampomagnolide B Derivatives App 20150133444 - Janganati; Venumadhav ; et al.	2015-05-14
Use Of Parthenolide Derivatives As Antileukemic And Cytotoxic Agents App 20150099731 - Crooks; Peter A. ; et al.	2015-04-09
Melampomagnolide B derivatives as antileukemic and cytotoxic agents Grant 8,884,027 - Crooks , et al. November 11, 2	2014-11-11
Use of parthenolide derivatives as antileukemic and cytotoxic agents Grant 8,716,329 - Crooks , et al. May 6, 2	2014-05-06
Use Of Parthenolide Derivatives As Antileukemic And Cytotoxic Agents App 20130288371 - Crooks; Peter A. ; et al.	2013-10-31
Use of parthenolide derivatives as antileukemic and cytotoxic agents Grant 8,470,875 - Crooks , et al. June 25, 2	2013-06-25
Use Of Parthenolide Derivatives As Antileukemic And Cytotoxic Agents App 20120165308 - Crooks; Peter A. ; et al.	2012-06-28
Melampomagnolide B Derivatives as Antileukemic and Cytotoxic Agents App 20120122943 - Crooks; Peter A. ; et al.	2012-05-17
Use of parthenolide derivatives as antileukemic and cytotoxic agents Grant 8,124,652 - Crooks , et al. February 28, 2	2012-02-28
Use Of Parthenolide Derivatives As Antileukemic And Cytotoxic Agents App 20100184745 - Crooks; Peter A. ; et al.	2010-07-22
Use of parthenolide derivatives as antileukemic and cytotoxic agents Grant 7,678,904 - Crooks , et al. March 16, 2	2010-03-16
Use of parthenolide derivatives as antileukemic and cytotoxic agents Grant 7,312,242 - Crooks , et al. December 25, 2	2007-12-25
Use of parthenolide derivatives as antileukemic and cytotoxic agents App 20050272716 - Crooks, Peter A. ; et al.	2005-12-08
Use of parthenolide derivatives as antileukemic and cytotoxic agents App 20050032886 - Crooks, Peter A. ; et al.	2005-02-10
Transduced Human Hematopoietic Stem Cells App 20020061293 - JORDAN, CRAIG T. ; et al.	2002-05-23

Company Registrations

NCAGE Code	4JFR8	JORDAN CRAIG T
CAGE Code	4JFR8	JORDAN, CRAIG T
DUNS	784809258	JORDAN, CRAIG T

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.